Join to View Full Profile
7130 N Millbrook AveSte 100Fresno, CA 93720
Phone+1 559-326-1222
Fax+1 559-326-1230
Dr. Aulakh is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Amardeep Aulakh, DO, is a specialist in Oncology based in Fresno, California. He completed his education in multiple prestigious universities, including University of California Davis Health, UMass Chan Medical School, and Texas Tech University Health Sciences Center at Lubbock. His experience is diverse including solid tumors and malignant hematology, focusing especially on areas such as breast cancer, lung, GI and GU cancers, myelodysplasia, myelofibrosis, and multiple myeloma. In addition to his clinical work, Dr. Aulakh is also a well-known published researcher, with his work cited multiple times by various publications, indicating his significant contributions to the field of oncology.
Education & Training
Texas Tech University Health Sciences Center at LubbockFellowship, Hematology and Medical Oncology, 2012 - 2014
University of California Davis HealthFellowship, Blood Banking/Transfusion Medicine, 2011 - 2012
UMass Chan Medical SchoolResidency, Internal Medicine, 2008 - 2011
Touro University CaliforniaClass of 2008
Certifications & Licensure
CA State License 2011 - 2026
TX State License 2012 - 2016
MA State License 2010 - 2013
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification ARIA Oncology Information System (for Medical Oncology), Varian Medical Systems, 2015-2017
- CMS Meaningful Use Stage 1 Certification ARIA oncology information system (for Medical Oncology), Varian Medical Systems, 2015-2017
- CMS Meaningful Use Stage 1 Certification ARIA Oncology Information System (for Radiation Oncology), Varian Medical Systems, 2015-2017
Publications & Presentations
PubMed
- 9 citationsNuclear Export as a Novel Therapeutic Target: The CRM1 ConnectionChuanwen Lu, Jose A. Figueroa, Zhongwei Liu, Venu Madhav Konala, Amardeep Aulakh
Current Cancer Drug Targets. 2015-08-31 - 60 citationsChimeric antigen receptor engineering: a right step in the evolution of adoptive cellular immunotherapy.Jose A. Figueroa, Adair Reidy, Leonardo Mirandola, Kayley Trotter, Natallia Suvorava
International Reviews of Immunology. 2015-04-22 - 30 citationsThe Role of Human Papilloma Virus (HPV) Infection in Non-Anogenital Cancer and the Promise of Immunotherapy: A ReviewChristopher J. Cobos, Jose A. Figueroa, Leonardo Mirandola, Michela Colombo, Gabby Summers
International Reviews of Immunology. 2014-10-03
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
